Illumina, OGT Betting Their New Chips Will Tap ‘Huge’ Cyto-Testing Market
November 18, 2008
Illumina, OGT Betting Their New Chips Will Tap ‘Huge’ Cyto-Testing Market
Illumina is new to the cytogenetics tools market and OGT formally launched arrays for the space last year. Their new products will play in a field crowded with offerings from rivals such as Affymetrix, BlueGnome, and Empire Genomics.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- People in the News: Gavin Wood, Tim Barabe
May 20, 2013 / BioArray News - Q&A: INMEGEN's Alfredo Hidalgo on Using Genomics to Address Mexico's Most Pressing Health Problems
May 17, 2013 / BioArray News - Royalties Drive up GeneNews Q1 Revenues Sharply
May 16, 2013 / GenomeWeb Daily News - Agilent Restructures, Laying off 450; Q2 Revenues Flat
May 15, 2013 / GenomeWeb Daily News - Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News